The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The role of conventional imaging and piflufolastat F18 in newly diagnosed and recurrent prostate cancer patients: Preliminary observations from the PYLARIFY Registry.
 
Neal Shore
Employment - GenesisCare
Consulting or Advisory Role - Accord Research; Alessa Therapeutics; Amgen; Antev; Arquer Diagnostics; Asieris Pharmaceuticals; Astellas Pharma; AstraZeneca; Aura Biosciences; Bayer; Bioprotect; Bristol-Myers Squibb/Sanofi; CG Oncology; Clarity Pharmaceuticals; Dendreon; Exact Imaging; Ferring; Fize Medical; Glytherix; InVitae; Janssen Scientific Affairs; Lantheus Medical Imaging; Lilly; MDxHealth; Medivation/Astellas; Merck; Minomic; Myriad Genetics; Novartis; Peerview; Pfizer; Photocure; PlatformQ Health; Promaxo; Propella Therapeutics; Protara Therapeutics; Sanofi; Siemens; Speciality Networks; Sumitomo Pharma Oncology; Telix Pharmaceuticals; Tolmar; Tutelix; Urogen pharma
Research Funding - Abbvie; Advantagene; Amgen; Aragon Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb/Pfizer; CG Oncology; Clovis Oncology; Dendreon; DisperSol; Endocyte; Exact Imaging; Exelixis; Ferring; FKD Therapies; FORMA Therapeutics; Foundation Medicine; Genentech; Guardant Health; InVitae; Istari Oncology; Janssen; Jiangsu Yahong Meditech; MDxHealth; Medivation; Merck; MT Group; Myovant Sciences; Myriad Genetics; Novartis; Nymox; OncoCellMDx; ORIC Pharmaceuticals; pacific edge; Palette Life Sciences; Pfizer; Plexxikon; POINT Biopharma; Propella Therapeutics; Propella Therapeutics; RhoVac; Sanofi; SeaGen; Sesen Bio; Steba Biotech; Theralase; Tolmar; Urogen pharma; Urotronic; US Biotest; Vaxiion; Veru; Zenflow
 
Lorraine O'Donnell
Employment - Cardinal Health
Research Funding - Abbvie (Inst); AnchorDX (Inst); Artera (Inst); Aura Biosciences (Inst); Bayer (Inst); Dendreon (Inst); Endo Pharmaceuticals (Inst); Ferring (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Lantheus Medical Imaging (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pacific Edge Biotechnology (Inst); SOBI (Inst); Telix Pharmaceuticals (Inst); Urovant Sciences (Inst)
 
Basil Wilson
Employment - Cardinal Health
Research Funding - Bayer (Inst); Dendreon (Inst); Janssen (Inst); Lantheus Medical Imaging (Inst); Lilly (Inst); Pfizer (Inst)
 
Shashank Dave
Employment - Cardinal Health
Research Funding - Dendreon (Inst); Lantheus Medical Imaging (Inst); Novartis (Inst)
 
Arpit Kashyap
Employment - Cardinal Health; SpringWorks Therapeutics (I)
Stock and Other Ownership Interests - SpringWorks Therapeutics (I)
Research Funding - Dendreon (Inst); Lantheus Medical Imaging (Inst); Lilly (Inst)
 
Nicholas Lazarou
Employment - Cardinal Health
Stock and Other Ownership Interests - Cardinal Health
Research Funding - Abbvie (Inst); AnchorDX (Inst); ArteraAI (Inst); Aura Biosciences (Inst); Bayer (Inst); Dendreon (Inst); Endo Pharmaceuticals (Inst); Ferring (Inst); GlaxoSmithKline (Inst); Johnson & Johnson (Inst); Lantheus Medical Imaging (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pacific Edge Biotechnology (Inst); SOBI (Inst); Sumitomo Corporation (Inst); Telix Pharmaceuticals (Inst)